Aveanna Healthcare Holdings EBITDA 2020-2026 | AVAH
Aveanna Healthcare Holdings ebitda from 2020 to 2026. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Aveanna Healthcare Holdings Annual EBITDA (Millions of US $) |
|
|---|---|
| 2025 | $291 |
| 2024 | $176 |
| 2023 | $148 |
| 2022 | $80 |
| 2021 | $126 |
| 2020 | $110 |
| 2019 | $73 |
|
Aveanna Healthcare Holdings Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2026-06-30 | $89 |
| 2026-03-31 | $78 |
| 2025-12-31 | $79 |
| 2025-09-30 | $62 |
| 2025-06-30 | $89 |
| 2025-03-31 | $60 |
| 2024-12-31 | $55 |
| 2024-09-30 | $43 |
| 2024-06-30 | $46 |
| 2024-03-31 | $33 |
| 2023-12-31 | $38 |
| 2023-09-30 | $37 |
| 2023-06-30 | $46 |
| 2023-03-31 | $27 |
| 2022-12-31 | $13 |
| 2022-09-30 | $16 |
| 2022-06-30 | $26 |
| 2022-03-31 | $26 |
| 2021-12-31 | $15 |
| 2021-09-30 | $27 |
| 2021-06-30 | $45 |
| 2021-03-31 | $39 |
| 2020-12-31 | $28 |
| 2020-09-30 | $22 |
| 2020-06-30 | $33 |
| 2020-03-31 | $27 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $3.123B | $2.433B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.581B | 13.26 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.179B | 14.91 |
| Encompass Health (EHC) | United States | $12.036B | 20.89 |
| Elanco Animal Health (ELAN) | United States | $11.491B | 21.70 |
| Chemed (CHE) | United States | $6.620B | 23.60 |
| RadNet (RDNT) | United States | $6.069B | 175.27 |
| LifeStance Health (LFST) | United States | $4.991B | 100.46 |
| Option Care Health (OPCH) | United States | $3.523B | 14.89 |
| Addus HomeCare (ADUS) | United States | $2.164B | 19.57 |
| Astrana Health (ASTH) | United States | $2.138B | 22.69 |
| Pennant (PNTG) | United States | $1.396B | 36.34 |
| U.S Physical Therapy (USPH) | United States | $1.220B | 32.19 |
| Daxor (DXR) | United States | $0.065B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.024B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |